For research use only. Not for therapeutic Use.
Pocapavir (Cat.No:I008810), also known as SCH-48973 and V-073, is a potent, selective, antienterovirus agent. SCH-48973 had antiviral activity (50% inhibitory concentrations [IC50s]) of 0.02 to 0.11 microg/ml, with no detectable cytotoxicity at 50 microg/ml. SCH-48973 inhibited 80% of 154 recent human enterovirus isolates at an IC50 of 0.9 microg/ml. The affinity constant (Ki) for SCH-48973 binding to poliovirus was 8.85 x 10(-8) M. SCH-48973 demonstrated efficacy in a murine poliovirus model of enterovirus disease. SCH-48973 represents a potential candidate for therapeutic intervention against enterovirus infections.
| Catalog Number | I008810 |
| CAS Number | 146949-21-5 |
| Synonyms | SCH-48973; SCH48973; SCH 48973; V074; V 073; V-073; Pocapavir.;1,3-dichloro-2-((4-((2-chloro-4-methoxyphenoxy)methyl)benzyl)oxy)benzene |
| Molecular Formula | C21H17Cl3O3 |
| Purity | ≥95% |
| Target | Enterovirus |
| Solubility | Soluble in DMSO, not in water |
| Storage | 0 - 4 °C for short term, or -20 °C for long term |
| Reference | </br>1:Antiviral Activity of Pocapavir in a Randomized, Blinded, Placebo-Controlled Human Oral Poliovirus Vaccine Challenge Model. Collett MS, Hincks JR, Benschop K, Duizer E, van der Avoort H, Rhoden E, Liu H, Oberste MS, McKinlay MA, Hartford M.J Infect Dis. 2017 Feb 1;215(3):335-343. doi: 10.1093/infdis/jiw542. PMID: 27932608 Free PMC Article</br>2:First use of investigational antiviral drug pocapavir (v-073) for treating neonatal enteroviral sepsis. Torres-Torres S, Myers AL, Klatte JM, Rhoden EE, Oberste MS, Collett MS, McCulloh RJ.Pediatr Infect Dis J. 2015 Jan;34(1):52-4. doi: 10.1097/INF.0000000000000497. PMID: 25229269 |
